Process View
Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of precursor metabolites, substances from which energy is derived, and the processes involved in the liberation of energy from these substances.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "regulation of generation of precursor metabolites and energy"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| INSR | insulin receptor | 0.994 | ||
| PGK1 | phosphoglycerate kinase 1 | 0.830 | ||
| PRKAB1 | protein kinase, AMP-activated, beta 1 non-catalytic subunit | 0.712 | ||
| GRB10 | growth factor receptor-bound protein 10 | 0.683 | Rat | |
| IGF1R | insulin-like growth factor 1 receptor | 0.644 | Human | |
| PPARGC1A | peroxisome proliferator-activated receptor gamma, coactivator 1 alpha | 0.617 | Mouse Rat | |
| PRKAB2 | protein kinase, AMP-activated, beta 2 non-catalytic subunit | 0.450 | ||
| HIPK2 | homeodomain interacting protein kinase 2 | 0.415 | ||
| DYRK1A | dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A | 0.377 | Human | |
| DYRK1B | dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1B | 0.343 | Human | |
| TP53 | tumor protein p53 | 0.330 | ||
| RXRA | retinoid X receptor, alpha | 0.269 | ||
| PRKCZ | protein kinase C, zeta | 0.265 | Human | |
| IRS1 | insulin receptor substrate 1 | 0.259 | ||
| NCF1 | neutrophil cytosolic factor 1 | 0.255 | ||
| IRS2 | insulin receptor substrate 2 | 0.235 | ||
| EEF2 | eukaryotic translation elongation factor 2 | 0.220 | ||
| TPI1 | triosephosphate isomerase 1 | 0.210 | ||
| YWHAE | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide | 0.201 | ||
| PTPN1 | protein tyrosine phosphatase, non-receptor type 1 | 0.176 | ||
| PPARG | peroxisome proliferator-activated receptor gamma | 0.138 | Human | |
| RARA | retinoic acid receptor, alpha | 0.131 | ||
| RB1 | retinoblastoma 1 | 0.126 | ||
| NCOR2 | nuclear receptor corepressor 2 | 0.115 | Human | |
| DCAF7 | DDB1 and CUL4 associated factor 7 | 0.109 | ||
| QARS | glutaminyl-tRNA synthetase | 0.108 | ||
| PPARA | peroxisome proliferator-activated receptor alpha | 0.108 | ||
| ESR1 | estrogen receptor 1 | 0.108 | ||
| HNF4A | hepatocyte nuclear factor 4, alpha | 0.106 | ||
| PPP2R5B | protein phosphatase 2, regulatory subunit B', beta | 0.101 | ||
| PDZD11 | PDZ domain containing 11 | 0.089 | ||
| SIN3A | SIN3 homolog A, transcription regulator (yeast) | 0.087 | ||
| NOXA1 | NADPH oxidase activator 1 | 0.086 | ||
| EP300 | E1A binding protein p300 | 0.080 | ||
| MDM2 | Mdm2 p53 binding protein homolog (mouse) | 0.080 | ||
| NR2E3 | nuclear receptor subfamily 2, group E, member 3 | 0.078 | ||
| NFYA | nuclear transcription factor Y, alpha | 0.075 | ||
| GSK3B | glycogen synthase kinase 3 beta | 0.073 | ||
| SP1 | Sp1 transcription factor | 0.069 | ||
| ITGB1BP3 | integrin beta 1 binding protein 3 | 0.064 | ||
| PPP1R2 | protein phosphatase 1, regulatory (inhibitor) subunit 2 | 0.064 | ||
| CCND1 | cyclin D1 | 0.055 | ||
| VHL | von Hippel-Lindau tumor suppressor | 0.052 | ||
| LZTS2 | leucine zipper, putative tumor suppressor 2 | 0.050 | ||
| CCND3 | cyclin D3 | 0.049 | ||
| MDM4 | Mdm4 p53 binding protein homolog (mouse) | 0.048 | ||
| NCOR1 | nuclear receptor corepressor 1 | 0.048 | ||
| RAF1 | v-raf-1 murine leukemia viral oncogene homolog 1 | 0.046 | ||
| HDAC1 | histone deacetylase 1 | 0.044 | ||
| MAFF | v-maf musculoaponeurotic fibrosarcoma oncogene homolog F (avian) | 0.043 | ||
| DYRK4 | dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 4 | 0.042 | Human | |
| PDPK1 | 3-phosphoinositide dependent protein kinase-1 | 0.042 | ||
| PARD6A | par-6 partitioning defective 6 homolog alpha (C. elegans) | 0.041 | ||
| CDK5 | cyclin-dependent kinase 5 | 0.040 | ||
| ENO1 | enolase 1, (alpha) | 0.040 | ||
| SH3RF1 | SH3 domain containing ring finger 1 | 0.038 | ||
| IGBP1 | immunoglobulin (CD79A) binding protein 1 | 0.037 | ||
| FAF1 | Fas (TNFRSF6) associated factor 1 | 0.036 | ||
| AKT1 | v-akt murine thymoma viral oncogene homolog 1 | 0.036 | ||
| STAT5B | signal transducer and activator of transcription 5B | 0.036 | ||
| PARD3 | par-3 partitioning defective 3 homolog (C. elegans) | 0.036 | ||
| PRKAG2 | protein kinase, AMP-activated, gamma 2 non-catalytic subunit | 0.036 | ||
| PPP1R9B | protein phosphatase 1, regulatory (inhibitor) subunit 9B | 0.035 | ||
| SIRT1 | sirtuin 1 | 0.035 | ||
| BAD | BCL2-associated agonist of cell death | 0.035 | ||
| SEMA6A | sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6A | 0.034 | ||
| ACTB | actin, beta | 0.034 | ||
| PARD6B | par-6 partitioning defective 6 homolog beta (C. elegans) | 0.033 | ||
| GAPDH | glyceraldehyde-3-phosphate dehydrogenase | 0.032 | ||
| DYRK2 | dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2 | 0.031 | ||
| BCL3 | B-cell CLL/lymphoma 3 | 0.031 | ||
| AKIP1 | A kinase (PRKA) interacting protein 1 | 0.028 | ||
| RYR2 | ryanodine receptor 2 (cardiac) | 0.028 | ||
| RAB6A | RAB6A, member RAS oncogene family | 0.027 | ||
| ACACA | acetyl-CoA carboxylase alpha | 0.027 | ||
| HDAC3 | histone deacetylase 3 | 0.026 | ||
| EXOSC5 | exosome component 5 | 0.026 | ||
| YWHAH | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide | 0.025 | ||
| GOT2 | glutamic-oxaloacetic transaminase 2, mitochondrial (aspartate aminotransferase 2) | 0.025 | ||
| NUMB | numb homolog (Drosophila) | 0.025 | ||
| CFL1 | cofilin 1 (non-muscle) | 0.025 | ||
| CLTC | clathrin, heavy chain (Hc) | 0.025 | ||
| BOK | BCL2-related ovarian killer | 0.025 | ||
| IGF2R | insulin-like growth factor 2 receptor | 0.024 | ||
| PTPN6 | protein tyrosine phosphatase, non-receptor type 6 | 0.024 | ||
| ESRRG | estrogen-related receptor gamma | 0.024 | ||
| PICK1 | protein interacting with PRKCA 1 | 0.024 | ||
| ENPP1 | ectonucleotide pyrophosphatase/phosphodiesterase 1 | 0.024 | ||
| HDAC5 | histone deacetylase 5 | 0.024 | ||
| SIGMAR1 | sigma non-opioid intracellular receptor 1 | 0.023 | ||
| NCOA1 | nuclear receptor coactivator 1 | 0.023 | ||
| SOCS1 | suppressor of cytokine signaling 1 | 0.023 | ||
| SETDB1 | SET domain, bifurcated 1 | 0.022 | ||
| ARF1 | ADP-ribosylation factor 1 | 0.022 | ||
| VEGFA | vascular endothelial growth factor A | 0.022 | ||
| EIF2D | eukaryotic translation initiation factor 2D | 0.022 | ||
| EPM2A | epilepsy, progressive myoclonus type 2A, Lafora disease (laforin) | 0.022 | ||
| PPP1CA | protein phosphatase 1, catalytic subunit, alpha isozyme | 0.022 | Rat | |
| PRKCB | protein kinase C, beta | 0.021 | ||
| RELA | v-rel reticuloendotheliosis viral oncogene homolog A (avian) | 0.021 | ||
| PRKAA2 | protein kinase, AMP-activated, alpha 2 catalytic subunit | 0.021 | Rat | |
| OSBP | oxysterol binding protein | 0.021 | ||
| BCL2L1 | BCL2-like 1 | 0.021 | ||
| CDKN1A | cyclin-dependent kinase inhibitor 1A (p21, Cip1) | 0.021 | ||
| PARD6G | par-6 partitioning defective 6 homolog gamma (C. elegans) | 0.020 | ||
| SRC | v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) | 0.020 | ||
| RAB8A | RAB8A, member RAS oncogene family | 0.020 | ||
| PGR | progesterone receptor | 0.020 | ||
| TBL1XR1 | transducin (beta)-like 1 X-linked receptor 1 | 0.020 | ||
| EIF3D | eukaryotic translation initiation factor 3, subunit D | 0.019 | ||
| HR | hairless homolog (mouse) | 0.018 | ||
| KAT2B | K(lysine) acetyltransferase 2B | 0.018 | ||
| PFKFB1 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1 | 0.018 | ||
| UBE2I | ubiquitin-conjugating enzyme E2I (UBC9 homolog, yeast) | 0.017 | ||
| CUX1 | cut-like homeobox 1 | 0.017 | ||
| CDCP1 | CUB domain containing protein 1 | 0.017 | ||
| PRKAA1 | protein kinase, AMP-activated, alpha 1 catalytic subunit | 0.017 | Rat | |
| INPPL1 | inositol polyphosphate phosphatase-like 1 | 0.017 | ||
| PREX1 | phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 1 | 0.016 | ||
| SLC25A6 | solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 6 | 0.016 | ||
| NCOA6 | nuclear receptor coactivator 6 | 0.016 | ||
| EIF3L | eukaryotic translation initiation factor 3, subunit L | 0.016 | ||
| MYC | v-myc myelocytomatosis viral oncogene homolog (avian) | 0.016 | Rat | |
| MEF2A | myocyte enhancer factor 2A | 0.016 | ||
| RUNX1 | runt-related transcription factor 1 | 0.015 | ||
| APPL1 | adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 1 | 0.014 | ||
| UBQLN4 | ubiquilin 4 | 0.014 | ||
| PILRA | paired immunoglobin-like type 2 receptor alpha | 0.014 | ||
| C11orf2 | chromosome 11 open reading frame 2 | 0.014 | ||
| PPP1R10 | protein phosphatase 1, regulatory (inhibitor) subunit 10 | 0.014 | ||
| MIF4GD | MIF4G domain containing | 0.014 | ||
| EPOR | erythropoietin receptor | 0.014 | ||
| SESN2 | sestrin 2 | 0.014 | ||
| SH2B1 | SH2B adaptor protein 1 | 0.014 | ||
| GRB14 | growth factor receptor-bound protein 14 | 0.013 | ||
| HDAC7 | histone deacetylase 7 | 0.013 | ||
| LDHA | lactate dehydrogenase A | 0.013 | ||
| IFNAR2 | interferon (alpha, beta and omega) receptor 2 | 0.013 | ||
| ARHGEF12 | Rho guanine nucleotide exchange factor (GEF) 12 | 0.013 | ||
| MLX | MAX-like protein X | 0.013 | ||
| USMG5 | up-regulated during skeletal muscle growth 5 homolog (mouse) | 0.013 | ||
| FAM117B | family with sequence similarity 117, member B | 0.013 | ||
| MED25 | mediator complex subunit 25 | 0.013 | ||
| AK2 | adenylate kinase 2 | 0.013 | ||
| MRPL14 | mitochondrial ribosomal protein L14 | 0.013 | ||
| PPP1CC | protein phosphatase 1, catalytic subunit, gamma isozyme | 0.013 | ||
| SOD1 | superoxide dismutase 1, soluble | 0.012 | ||
| CDKN2A | cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) | 0.012 | ||
| CDK6 | cyclin-dependent kinase 6 | 0.012 | ||
| HDAC4 | histone deacetylase 4 | 0.012 | Mouse | |
| MAPKAP1 | mitogen-activated protein kinase associated protein 1 | 0.012 | ||
| GHR | growth hormone receptor | 0.012 | ||
| MAP1LC3A | microtubule-associated protein 1 light chain 3 alpha | 0.012 | ||
| FOXO3 | forkhead box O3 | 0.012 | ||
| SKI | v-ski sarcoma viral oncogene homolog (avian) | 0.012 | ||
| JAK2 | Janus kinase 2 | 0.012 | ||
| CYBA | cytochrome b-245, alpha polypeptide | 0.012 | ||
| PKM2 | pyruvate kinase, muscle | 0.012 | ||
| DAXX | death-domain associated protein | 0.012 | ||
| BCL6 | B-cell CLL/lymphoma 6 | 0.012 | ||
| MGEA5 | meningioma expressed antigen 5 (hyaluronidase) | 0.012 | ||
| FXN | frataxin | 0.012 | ||
| SMAD3 | SMAD family member 3 | 0.012 | ||
| SH3RF3 | SH3 domain containing ring finger 3 | 0.012 | ||
| SETD7 | SET domain containing (lysine methyltransferase) 7 | 0.012 | ||
| AKAP8L | A kinase (PRKA) anchor protein 8-like | 0.011 | ||
| PPIF | peptidylprolyl isomerase F | 0.011 | Mouse | |
| SPRED1 | sprouty-related, EVH1 domain containing 1 | 0.011 | ||
| HSPA13 | heat shock protein 70kDa family, member 13 | 0.011 | ||
| GCKR | glucokinase (hexokinase 4) regulator | 0.011 | ||
| PSEN2 | presenilin 2 (Alzheimer disease 4) | 0.011 | ||
| SORBS2 | sorbin and SH3 domain containing 2 | 0.011 | ||
| HMOX2 | heme oxygenase (decycling) 2 | 0.011 | ||
| CDK4 | cyclin-dependent kinase 4 | 0.011 | ||
| BCL2L11 | BCL2-like 11 (apoptosis facilitator) | 0.011 | ||
| SEC24D | SEC24 family, member D (S. cerevisiae) | 0.011 | ||
| LAIR1 | leukocyte-associated immunoglobulin-like receptor 1 | 0.011 | ||
| C20orf24 | chromosome 20 open reading frame 24 | 0.011 | ||
| BMX | BMX non-receptor tyrosine kinase | 0.010 | ||
| IGFBP3 | insulin-like growth factor binding protein 3 | 0.010 | ||
| ARFGAP3 | ADP-ribosylation factor GTPase activating protein 3 | 0.010 | ||
| EEF1D | eukaryotic translation elongation factor 1 delta (guanine nucleotide exchange protein) | 0.010 | ||
| PAG1 | phosphoprotein associated with glycosphingolipid microdomains 1 | 0.010 | ||
| MRPS12 | mitochondrial ribosomal protein S12 | 0.010 | ||
| WAS | Wiskott-Aldrich syndrome (eczema-thrombocytopenia) | 0.010 | ||
| MAP3K1 | mitogen-activated protein kinase kinase kinase 1 | 0.010 | ||
| FBP2 | fructose-1,6-bisphosphatase 2 | 0.010 | Human | |
| TXNIP | thioredoxin interacting protein | 0.010 |